Replies to post #110773 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

Gottlieb says...

FDA’s headway in pursuing the opportunities enabled by Cures illustrates the agency’s enthusiasm and commitment to the law—both its letter and its spirit.”

Wow, from an organization like FDA it is a leap to go from effective treatment to CURES.



One wonders how decades of CNS-AD plaque correlations will be treated by the history books. Finally, the FDA is moving to lead from the front. Dr. M. is on the right path.